BioCentury
ARTICLE | Clinical News

Two undisclosed oncology products regulatory update

May 10, 2004 7:00 AM UTC

Following pre-approval cGMP inspection of an Ethypharm manufacturing facility for two undisclosed oncology products, FDA made two observations on Form 483, the company said. Form 483 is used by FDA in...